Phase 3 Interstitial Lung Disease trials recruiting now

All Interstitial Lung Disease trials, every phase

Other phases for Interstitial Lung Disease

Phase 3 Interstitial Lung Disease trials

• A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
  NCT07816185 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 3 locations
• An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07234032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 145 locations
• Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
  NCT07613099 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.